Ninh Doan, Karl Janich, Ha S Nguyen, Mohit Patel, Saman Shabani and Andrew Montoure
Chronic subdural hematoma (cSDH) is a common neurosurgical pathology associated with prior traumatic brain injury (TBI) and older age that is often complicated by antiplatelet or anticoagulant therapies. cSDH often results from the liquefaction of a previous acute subdural hematoma that accompanies TBI. The incidence of cSDH will likely increase over the next 25 years, placing a burden on health care costs. As such, a simple, inexpensive treatment option is desirable. In this short communication, we describe recent data and different techniques that are available for treating cSDH.